PRODUCT DETAILS (US)
FiberNet® EP System Design
Clinical Experience
Currently for investigational use only, the FiberNet system has been evaluated in over 200 patients worldwide. Enrolling trials include the recently initiated EPIC Pivotal Trial in the U.S. and EPIC Europe for the carotid artery indication, and the RETREIVE feasibility study for the saphenous vein graft indication.
Notice of Availability
Caution
Investigational device, limited by Federal Law to Investigational Use.
Contact Us Today
For more information on the FiberNet system and participation in ongoing or future investigational trials, contact us today.
May 18, 2009
Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter
Learn More
January 29, 2009
Invatec Announces Worldwide Distribution Agreement with Lumen Biomedical
Learn More
November 19, 2008
FDA Approves Lumen Biomedical’s FiberNet Embolic Protection System for Carotid Artery Stenting
Learn More
October 22, 2008
Lumen Biomedical Receives FDA Clearance of Embolectomy System for Treatment of Peripheral Artery Disease
Learn More
October 16, 2008
FiberNet EPS Clinical Trial Results
Learn More
October 3, 2008
Lumen Presence at TCT Conference
Learn More
January 1, 2008
Fibernet® Embolic Protection System, Exploring the Differences. Featured Technology, Endovascular Today
Learn More
